Mulmit

Artiva Biotherapeutics, Inc.Artiva Biotherapeutics, Inc.

ARTV Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-310-89,810,000-83,865,000-3.43
2024-12-31251,000-67,282,000-65,373,000-5.81
2023-12-3133,492,000-30,671,000-28,720,000-35.78

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-08-27Banerjee SubhashisChief Medical Officer5,306
2026-08-27Banerjee SubhashisChief Medical Officer8,222
2026-08-27Banerjee SubhashisChief Medical Officer5,306
2026-08-18Banerjee SubhashisChief Medical Officer429
2026-08-18Banerjee SubhashisChief Medical Officer429
2026-08-18Banerjee SubhashisChief Medical Officer429
2026-07-31RA CAPITAL MANAGEMENT, L.P.24,944
2026-07-29RA CAPITAL MANAGEMENT, L.P.20,824
2026-07-24RA CAPITAL MANAGEMENT, L.P.41,319
2026-07-23RA CAPITAL MANAGEMENT, L.P.59,880
2026-07-22RA CAPITAL MANAGEMENT, L.P.84,124
2026-07-21RA CAPITAL MANAGEMENT, L.P.120,582

8-K events

FiledItems
2026-08-06Results of operations · Financial statements and exhibits
2026-07-22Other events
2026-05-19Officer or director change
2026-05-08Other events · Financial statements and exhibits
2026-05-08Results of operations · Regulation FD disclosure · Other events · Financial statements and exhibits
2026-03-10Results of operations · Financial statements and exhibits
2026-02-24Officer or director change
2026-02-19Officer or director change
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…